Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

People whose symptoms make it highly likely they have obstructive sleep apnea (OSA) can safely start treatment without first obtaining a confirmatory diagnosis in a sleep laboratory. So concludes a ...

LIVERPOOL, N.Y. (WSYR-TV) — Sleep apnea isn’t just something that affects older adults anymore. Experts say they’re seeing ...

While most of us treat a sleep study as a one-night inconvenience, researchers are now turning that single session into a detailed forecast of future health. A new artificial intelligence model from ...

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, while effective, are often hindered by poor ...

Assessing mean apnea-hypopnea duration (MAD) in patients with OSA yields hypoxemia and symptom burden data not provided by the AHI or ODI.

Medically reviewed by Daniel Combs, MD Key Takeaways Obstructive sleep apnea (OSA) occurs when the upper airway gets blocked ...

Graham Goodrich, CCO, Apnimed, outlines how advances in diagnostics, growing recognition of sleep apnea’s systemic impact, ...

Sleep apnea at age 50 and over is linked to a higher risk of dementia- especially among women. The findings offer new insight into the role of sleep apnea on long-term cognitive health. The ...

Need answers on why you can’t fall or stay asleep? Williamson Health has a solution — their Sleep Lab, a comprehensive diagnostic testing clinic for treatment of sleep disorders. "The newly renovated ...